中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共3条，第1-3条 帮助

已选(0)清除 条数/页：   排序方式：
Anlotinib plus radiotherapy-temozolomide for newly diagnosed glioblastoma: A prospective, multicenter phase II study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Lai, Shuzhen;  Chen, Yuan Yuan Yuan;  Li, Peijing;  Jiang, Fagui;  Liu, Xiaohui;  Tao, Changjuan;  Huang, Jing;  Tang, Yiqiang;  Liu, Zhigang;  Shen, Guoping;  Li, Chaoming;  Xie, Tieming;  Lu, Fangxiao;  Liu, Guihong
收藏  |  浏览/下载：25/0  |  提交时间：2022/12/23
Room temperature Raman spectroscopy and Si-29 MAS NMR combined with high temperature Raman spectroscopy and DFT calculation of xMgO-(1-x) CaO-SiO2 glasses and melts 期刊论文
CERAMICS INTERNATIONAL, 2022, 卷号: 48
作者:  Gong, Xiaoye;  Wang, Jian;  You, Jinglin;  Wang, Min;  Tang, Xiaohui;  Zhang, Fu;  Tang, Kai;  Lu, Liming;  Wan, Songming;  Zhang, Qingli
收藏  |  浏览/下载：86/0  |  提交时间：2022/03/28
In-situ Raman spectroscopy  29 Si MAS NMR  DFT calculation  Quantitative analysis  
A phase II study of anlotinib combined with STUPP regimen in the treatment of patients with newly diagnosed glioblastoma (GBM). 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Li, Peijing;  Chen, Yuan Yuan Yuan;  Lai, Shuzhen;  Jiang, Fagui;  Liu, Xiaohui;  Tao, Changjuan;  Wang, Lei;  Liu, Guihong;  Huang, Jing;  Tang, Yiqiang;  Liu, Zhigang;  Shen, Guoping;  Li, Chaoming;  Xie, Tieming;  Lu, Fangxiao
收藏  |  浏览/下载：57/0  |  提交时间：2022/01/10